StemSave Blog

Researchers at University of Glasgow have developed a new “nanokicking” technology, which directs mesenchymal stem cells to precisely differentiate into a bone material for use in fracture repairs and bone grafting. By subjecting the stem cells to ‘nanokicking’ – precise, nanoscale vibrations, while the cells are in a collagen gel, these cells can more effectively transform into bone cells capable of replenishing damaged or depleted bone mass. Current bone grafts obtained from patients themselves nearly never yield enough bone material to be clinically relevant for severe injuries, and donor bone grafts have a high risk of rejection hence, autologous stem cell grafts represent an optimal treatment option for patients suffering from any type of bone trauma or deficiency. With bone being the second most grafted tissue [behind blood], ‘nanokicking’ the patient’s own stem cells would significantly impact patient outcomes following reconstructive, maxillofacial and orthopedic surgeries.